Details
-
Change Request
-
Resolution: Persuasive
-
Low
-
Electronic Medicinal Product Information (FHIR)
-
1.0.0-ballot
-
Biomedical Research & Regulation
-
STU
-
Introduction
-
-
Correction
-
Non-substantive
-
1.0.0-ballot
Description
- remove the sentence "FHIR resources: List Bundle Composition Organization Regulated Authorization Medicinal Product Definition Administrable Product Definition Manufactured Item Definition Ingredient Substance Definition Packaged Product Definition Clinical Use Definition Binary" (no added value in this list)
- change "to be a common starting point to build region specific profiles"
into
"to be a common starting (Base ePI Profile + link to the 1.5.1 section) point to build region or country specific profiles (Regional or National ePI Profile + link to the 1.5.2 section)" - Remove "The national FHIR ePI profiles were defined by representatives from the health authority for the corresponding jurisdiction, representatives from Gravitate Health, and HL7's Vulcan Accelerator. On behalf of the international community and health authorities, this guide is maintained by HL7's Biomedical Research and Regulation (BR&R) Working Group" there are no national / regional profiles in this guide
- revise or remove the sentence "This guide will be reviewed annually for active use, obsolescence, and potential need for change."
Not sure that an annual review is what we should look for. Should we wait one year if an errata should be published ?
- Clarify the Co-Lead and Technical Lead roles in § 1.8 (lead of what ?)
- fix Technical Leads (Technical Lead)
- Tech Lead or Tech co-lead ?
Attachments
Issue Links
- is voted on by
-
BALLOT-46239 Negative - Giorgio Cangioli : 2023-Jan-FHIR IG EMEDICINAL PRODUCT INFO R1 STU
- Balloted